Anti-Kappa Opioid Receptor antibody
- BOND RX™ Validated
- What is this?
4
(3 Reviews)
|
(4 Publications)
Rabbit Polyclonal Kappa Opioid Receptor antibody. Suitable for WB, ICC/IF, IHC-P and reacts with Human samples. Cited in 4 publications.
View Alternative Names
OPRK, OPRK1, Kappa-type opioid receptor, K-OR-1, KOR-1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Kappa Opioid Receptor antibody (AB113533)
IHC image of Kappa Opioid Receptor staining in Human normal placenta formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab113533, 5μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Kappa Opioid Receptor antibody (AB113533)
ab113533 stained SKNSH cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab113533 at 5μg/ml overnight at +4°C. The secondary antibody (green) was DyLight® 488 goat anti- rabbit (ab96899) IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.
- WB
Lab
Western blot - Anti-Kappa Opioid Receptor antibody (AB113533)
This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab113533 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution ab133406.
All lanes:
Western blot - Anti-Kappa Opioid Receptor antibody (ab113533) at 1 µg/mL
Lane 1:
Human brain tissue lysate - total protein at 10 µg
Lane 2:
Human spinal cord tissue lysate - total protein at 10 µg
Lane 3:
Human placenta tissue lysate - total protein at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG H&L (HRP) preadsorbed at 1/50000 dilution
Predicted band size: 42 kDa
Observed band size: 42 kDa,52 kDa
false
Exposure time: 3min
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Kappa opioid receptors mediate pain perception mood regulation and stress response. They form part of a larger receptor family the G-protein coupled receptors (GPCRs) which are critical in cellular signaling. Activation of these receptors can produce analgesic effects differing from other opioid receptors due to their unique mechanism of action. Kappa receptors interact with endogenous ligands called dynorphins which are peptide neurotransmitters involved in natural pain relief processes.
Pathways
Kappa opioid receptors are integral to the dopaminergic and serotonergic pathways. In the dopaminergic pathway kappa receptors reduce dopamine release influencing the reward system and potentially affecting addiction behaviors. In the serotonergic pathway they modulate serotonin levels connecting to mood and anxiety regulation. These pathways also involve proteins like the mu-opioid receptor and delta-opioid receptor which along with kappa receptors form a complex regulatory network.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Cell biology and toxicology 41:97 PubMed40483281
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:844214 PubMed35433440
2022
Applications
Unspecified application
Species
Unspecified reactive species
Neural regeneration research 16:653-658 PubMed33063716
2020
Applications
Unspecified application
Species
Unspecified reactive species
Molecular reproduction and development 83:724-34 PubMed27391529
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com